Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected1Y Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | BIIB | ABBV | AMGN |
|---|---|---|---|
| Return | |||
| Last Price | — | 256.46 | — |
| Daily Change | — | − 1.44% | — |
| Period ReturnPast Year | + 58.15% | + 21.02% | + 52.39% |
| Valuation | |||
| Market Cap | $32.6 B | $453 B | $224 B |
| P/E Ratio | — | 72.05 | — |
| Dividend Yield | — | 4.47% | — |
| Net MarginTrailing 12M | 8.3% | 9.8% | — |
| Risk | |||
| Beta | 0.12 | 0.20 | — |
| 52-Week Range | 135.39 — $225.80 | 190.75 — $267.47 | — |
| Company | |||
| Sector | Health Care | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- BIIBHealth Care · Biotechnology
- ABBVHealth Care · Biotechnology
- AMGNHealth Care · Biotechnology
Metrics could not be loaded for AMGN: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 23:00
To Understand This